Two Sigma Securities’s AnaptysBio ANAB Stock Holding History

Two Sigma Securities’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,101	Closed	-$212K	–	2650
2017 Q4	$212K	Buy	+2,101	New	+$155K	0.01%	1265

Other funds holding ANAB

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Two Sigma Securities's ANAB Position: Q1 2018 in Review

Two Sigma Securities sold out of AnaptysBio (ANAB) in Q1 2018, closing a stake of 2,101 shares — an estimated $212K sold.

Two Sigma Securities first reported a position in ANAB in Q4 2017 and held it in 1 quarter. The position peaked at $212K in Q4 2017. 134 funds tracked by Wall St. Rank hold ANAB as of Q1 2018.

Two Sigma Securities reported no remaining AnaptysBio position as of Q1 2018 after selling out during the quarter.
Two Sigma Securities sold 2,101 AnaptysBio shares in Q1 2018, an estimated $212K.
Two Sigma Securities first reported a position in AnaptysBio in Q4 2017 and held it in 1 quarter.
Two Sigma Securities's AnaptysBio position peaked at $212K in Q4 2017.
134 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2018.

Based on Two Sigma Securities's 13F filing for Q1 2018, filed 15 May 2018.